Interventional cardiologists have a name for chronic total occlusions. The last frontier. They are the lesions that humble experienced operators, that get referred between centers, that turn a routine list into a three-hour battle. Underneath all the technique and hardware, the thing that most often decides them is brutally simple: can the operator see where to go.

The same problem runs down the leg, where the stakes climb from a failed procedure to a threatened limb. I want to lay out the visibility gap at the center of both, what the field’s elaborate workarounds reveal about it, and why I treat the payoff as an open question rather than a claim.

The cap problem in the heart

Experienced operators cross chronic total occlusions in roughly 85 to 90 percent of cases. That sounds high until you sit with the variance. Outside expert hands the number drops, sometimes steeply, and the failures are not random. They cluster around predictable anatomy.

One of the strongest predictors of failure is proximal cap ambiguity. In plain terms, the operator cannot clearly tell where the occlusion begins or where to enter it. They are working at the face of a blockage they cannot see well. Length, calcium, and tortuosity make it worse, but the cap is the one that tends to decide, because if you cannot find the door, little else you do matters.

How operators grade the dark

There is something revealing in how the field scores these lesions before touching them. The difficulty scores operators use to predict whether a CTO can be crossed are, read closely, catalogues of what cannot be seen.

One widely used score weights a blunt or ambiguous stump, heavy calcification, bending within the occlusion, and length. Another, built to predict technical success, leads with ambiguous proximal cap and proximal tortuosity. Strip the clinical language and these are lists of the ways an operator is forced to proceed without a clear view.

The field has effectively quantified its own blindness and turned it into a planning tool. That is ingenious, and it is also a tell. You do not build elaborate systems to predict the consequences of a problem you can see your way around.

What do operators do when the cap is ambiguous? They study a pre-procedure scan, knowing it is a static picture of a moving target. They probe with wires. They go retrograde, adding a second access point to reach the occlusion from the far side. They thread a side-view ultrasound probe in from a branch to infer the cap sideways. Every one of these is a sophisticated way to compensate for not being able to look forward at the cap directly.

The cost of time, and of working blind

Each of those workarounds spends the one resource a CTO procedure cannot spare, which is time, and the registries are unusually clear that as the minutes accumulate the probability of success falls. Time is not a neutral cost. It is contrast load on the kidneys, radiation on the patient and the operator, fatigue, and a rising chance the case is abandoned. There is a second cost, too: blind probing and aggressive wire work are associated with complications, including perforation, which climbs with difficulty and with the retrograde techniques that ambiguity forces operators to adopt.

The point I want to draw is narrow and structural. The minutes and the risk go to finding the entry and feeling for the path, which is precisely the thing a forward view, if one existed, would be aimed at.

Down the leg, where the stakes are a limb

Take the same problem below the knee, into critical limb ischemia, and the consequences change character. Peripheral arterial disease affects more than two hundred million people worldwide. In its most severe form the occlusions are long, densely calcified, and stacked in the small vessels of the lower leg, in exactly the patients, often diabetic, often on dialysis, who can least afford a failure.

The operator threads a wire through a vessel they can barely visualize, trying to stay inside a true lumen that keeps vanishing into calcium. Lose it, and the wire slips subintimal, and re-entering the true lumen in a heavily calcified vessel is difficult, with rupture as the downside. Immediate failure of these crossings is common, a meaningful share of cases, and repeat procedures within a year are common rather than rare.

The field has the same tell here that it has in the coronaries: dedicated difficulty scores, and bail-out techniques built around threading a side-view probe alongside the wire to check, sideways, whether it is still in the lumen.

The cascade, told honestly

Here is where the stakes turn serious, and where the honest version is more persuasive than the dramatic one. A failed crossing often pushes the patient toward bypass surgery, and a failed bypass shortens the odds on the limb. The path from the operator could not see to the patient lost a leg is real, but it is not a straight line and it is not imaging alone.

Disease severity, runoff, wound status, and comorbidity all weigh on the outcome. What imaging touches is one recurring, upstream factor, whether the wire stayed in the right channel through a vessel the operator could not see. I will not claim more than that, because more than that has not been shown.

What the experts already do, and what it reveals

The strongest evidence that a forward view is the missing piece is what the best operators have already built to compensate for not having it. In the most difficult below-the-knee cases, leading operators thread a side-view ultrasound probe alongside the wire and use it to check, sideways and intermittently, whether they are still in the lumen. They have named these techniques. They teach them. They have turned the absence of a forward view into a discipline, an elaborate, skilled, painstaking discipline practiced by a handful of masters at a handful of centers.

Read that the right way and it is not a counterargument. It is the argument. When the most capable people in a field invent intricate workarounds to approximate, sideways and after the fact, a thing they cannot do directly, they are telling you what the field is missing. The side-view bail-out is, in effect, forward-viewing performed the hard way, by inference, by the only people skilled enough to pull it off.

Why this is an open question, and why it still matters

I want to be disciplined about the leap from here to outcomes. Whether a direct forward view would raise crossing rates, shorten cases, or reduce complications is an empirical question, and the honest answer today is that it would have to be earned with evidence, not assumed. The mechanism is plausible and it lines up with everything the difficulty scores tell us about why these cases fail. That is a reason to take the question seriously, not a result.

What makes it interesting to me, as someone who looks for where a market is structurally constrained, is the operator-dependence. These outcomes hinge on a small number of masters who learned, over thousands of cases, to feel their way through the dark, which is exactly what keeps the procedures concentrated in a few expert centers.

Any technology that narrowed the gap between the top operator and the competent one would be addressing a category constraint, not only a clinical one. Whether a forward view is that technology is unproven.

That it would be aimed at the right constraint is, to me, the reason to watch the space.

The honest limits

None of this erases hard anatomy. A forward view would not soften calcium or straighten a tortuous vessel, and it would not turn a novice into an expert. The toughest occlusions would still be tough, and skill and judgment would still decide most of the case. It would be one input added to the ones operators already trust, and its value would have to be demonstrated rather than asserted.

I find the visibility gap worth watching not because the answer is in hand, but because the field’s own workarounds keep pointing at the same missing view.